Castle Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Castle Biosciences Stock Summary

Castle Biosciences competes with Caredx, Twist Bioscience, Biodesix, Natera, and Fonar. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. The company was founded in 2007 and is headquartered in Friendswood, Texas. Castle Biosciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 482 people.

Castle Biosciences Key Financial Ratios

Castle Biosciences Key Balance Sheet Accounts

Castle Biosciences Key Income Statement Accounts

Castle Biosciences Key Cash Accounts

Castle Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Castle Biosciences's current stock value. Our valuation model uses many indicators to compare Castle Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Castle Biosciences competition to find correlations between indicators driving Castle Biosciences's intrinsic value. More Info.Castle Biosciences is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At this time, Castle Biosciences' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Castle Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Castle Biosciences Systematic Risk

Today, most investors in Castle Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Castle Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Castle Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Castle Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Castle Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Castle Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Castle Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Castle Biosciences's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.